Literature DB >> 24307740

Massive benefits of antiretroviral therapy in Africa.

Sten H Vermund1.   

Abstract

Keywords:  Africa; HIV; antiretroviral therapy; health policy; modeling; mortality; outcomes

Mesh：

Substances：

Year:  2013        PMID： 24307740      PMCID： PMC3903380          DOI： 10.1093/infdis/jit586

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  36 in total

1.  The President's Emergency Plan for AIDS Relief: from successes of the emergency response to challenges of sustainable action.

Authors:  Michael H Merson; James W Curran; Caroline Hope Griffith; Braveen Ragunanthan
Journal:  Health Aff (Millwood)       Date:  2012-07       Impact factor: 6.301

2.  Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR).

Authors:  Nancy S Padian; Charles B Holmes; Sandra I McCoy; Rob Lyerla; Paul D Bouey; Eric P Goosby
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

3.  Addressing poor retention of infants exposed to HIV: a quality improvement study in rural Mozambique.

Authors:  Philip J Ciampa; José A Tique; Nilton Jumá; Mohsin Sidat; Troy D Moon; Russell L Rothman; Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

4.  Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.

Authors:  Jeffrey D Klausner; Celicia Serenata; Heidi O'Bra; Christine L Mattson; J W Brown; Melinda Wilson; Thobile Mbengashe; Thurma M Goldman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes.

Authors:  Eran Bendavid; Jayanta Bhattacharya
Journal:  Ann Intern Med       Date:  2009-04-06       Impact factor: 25.391

Review 6.  Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

Authors:  Wafaa M El-Sadr; Charles B Holmes; Peter Mugyenyi; Harsha Thirumurthy; Tedd Ellerbrock; Robert Ferris; Ian Sanne; Anita Asiimwe; Gottfried Hirnschall; Rejoice N Nkambule; Lara Stabinski; Megan Affrunti; Chloe Teasdale; Isaac Zulu; Alan Whiteside
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

Review 7.  Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief.

Authors:  Benjamin H Chi; Michelle R Adler; Omotayo Bolu; Dorothy Mbori-Ngacha; Didier K Ekouevi; Anna Gieselman; Tsungai Chipato; Chewe Luo; B Ryan Phelps; Craig McClure; Lynne M Mofenson; Jeffrey S A Stringer
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

8.  Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009.

Authors:  Elysia Larson; Heidi O'Bra; J W Brown; Thobile Mbengashe; Jeffrey D Klausner
Journal:  BMC Public Health       Date:  2012-03-09       Impact factor: 3.295

9.  Modelling the impact of antiretroviral use in resource-poor settings.

Authors:  Rebecca F Baggaley; Geoff P Garnett; Neil M Ferguson
Journal:  PLoS Med       Date:  2006-03-14       Impact factor: 11.069

10.  The survival benefits of antiretroviral therapy in South Africa.

Authors:  Michael D April; Robin Wood; Bethany K Berkowitz; A David Paltiel; Xavier Anglaret; Elena Losina; Kenneth A Freedberg; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226
View more
  6 in total

Review 1.  Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.

Authors:  Clement A Adebamowo; Corey Casper; Kishor Bhatia; Sam M Mbulaiteye; Annie J Sasco; Warren Phipps; Sten H Vermund; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

2.  Global HIV epidemiology: A guide for strategies in prevention and care.

Authors:  Sten H Vermund
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

3.  Conspiracy beliefs and knowledge about HIV origins among adolescents in Soweto, South Africa.

Authors:  Robert Hogg; Busisiwe Nkala; Janan Dietrich; Alexandra Collins; Kalysha Closson; Zishan Cui; Steve Kanters; Jason Chia; Bernard Barhafuma; Alexis Palmer; Angela Kaida; Glenda Gray; Cari Miller
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

4.  Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.

Authors:  Andrew G Flynn; David B Meya; Katherine Huppler Hullsiek; Joshua Rhein; Darlisha A Williams; Abdu Musubire; Bozena M Morawski; Kabanda Taseera; Alisat Sadiq; Liberica Ndyatunga; Mollie Roediger; Radha Rajasingham; Paul R Bohjanen; Conrad Muzoora; David R Boulware
Journal:  Open Forum Infect Dis       Date:  2017-04-19       Impact factor: 3.835

5.  Outcomes of patients lost to follow-up after antiretroviral therapy initiation in rural north-eastern South Africa.

Authors:  Julie Ambia; Chodziwadziwa Kabudula; Kathryn Risher; Francesc Xavier Gómez-Olivé; Brian D Rice; David Etoori; Georges Reniers
Journal:  Trop Med Int Health       Date:  2019-04-09       Impact factor: 2.622

6.  Role of religious beliefs in adherence to antiretroviral therapy in the Cape Town metropole: a study protocol.

Authors:  Ivo Nchendia Azia; Shernaaz Carelse; Anam Nyembezi; Ferdinand C Mukumbang
Journal:  BMJ Open       Date:  2022-09-14       Impact factor: 3.006
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.